Literature DB >> 23604451

[Cystectomy in the elderly patient].

G Bartsch1, K Gust, S Vallo, C Bartsch, I Tsaur, J Mani, A Haferkamp.   

Abstract

Bladder cancer is a carcinoma of the elderly population. The highest incidence of bladder cancer is between the ages of 70 and 80 years old. Radical cystectomy remains the gold standard for muscle invasive bladder cancer treatment. In this article different aspects of radical cystectomy in elderly patients are reviewed. The Pubmed-MEDLINE database was searched using the following keywords: radical, cystectomy, elderly and age.

Entities:  

Mesh：

Year:  2013        PMID： 23604451     DOI： 10.1007/s00120-013-3196-3

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  71 in total

1.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.

Authors:  Badrinath R Konety; Vibhu Dhawan; Veerasathpurush Allareddy; Sue A Joslyn
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

2.  Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.

Authors:  Roman Mayr; Mattias May; Thomas Martini; Michele Lodde; Evi Comploj; Armin Pycha; Jenny Strobel; Stefan Denzinger; Wolfgang Otto; Wolfgang Wieland; Maximilian Burger; Hans-Martin Fritsche
Journal:  Eur Urol       Date:  2012-04-12       Impact factor: 20.096

3.  The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.

Authors:  Firas Abdollah; Maxine Sun; Shahrokh F Shariat; Jan Schmitges; Orchidee Djahangirian; Zhe Tian; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

4.  Quality of life survey of urinary diversion patients: comparison of continent urinary diversion versus ileal conduit.

Authors:  Y Okada; K Oishi; Y Shichiri; Y Kakehi; A Hamaguchi; T Tomoyoshi; O Yoshida
Journal:  Int J Urol       Date:  1997-01       Impact factor: 3.369

Review 5.  Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer.

Authors:  Siamak Daneshmand; Georg Bartsch
Journal:  Expert Rev Anticancer Ther       Date:  2011-06       Impact factor: 4.512

6.  Health-related quality of life with orthotopic neobladder versus ileal conduit according to the SF-36 survey.

Authors:  M Fujisawa; S Isotani; A Gotoh; H Okada; S Arakawa; S Kamidono
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

7.  Does body mass index affect outcome after reconstruction of orthotopic neobladder?

Authors:  Martha A Reyes; Alan M Nieder; Bruce R Kava; Mark S Soloway; Murugesan Manoharan
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

Review 8.  Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.

Authors:  Cora N Sternberg
Journal:  Semin Oncol       Date:  2007-04       Impact factor: 4.929

9.  Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.

Authors:  Filippo Sogni; Maurizio Brausi; Bruno Frea; Carlo Martinengo; Fabrizio Faggiano; Alessandro Tizzani; Paolo Gontero
Journal:  Urology       Date:  2008-03-20       Impact factor: 2.649

10.  Robotic-assisted laparoscopic intracorporeal urinary diversion.

Authors:  Raj S Pruthi; Jeff Nix; Dan McRackan; Adam Hickerson; Matthew E Nielsen; Matthew Raynor; Eric M Wallen
Journal:  Eur Urol       Date:  2010-01-09       Impact factor: 20.096
View more
  1 in total

1.  [Complications after ileal conduit: Urinary diversion-associated complications after radical cystectomy].

Authors:  F Roghmann; M Gockel; J Schmidt; J Hanske; N von Landenberg; B Löppenberg; K Braun; C von Bodman; J Pastor; J Palisaar; J Noldus; M Brock
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.